... (OR) associated with IPMN as a predictor of pancreas cancer and to derive a Wald 95% confidence interval for the OR. IPMN is considered a premalignant lesion and a potential precursor to pancreatic adenocarcinoma [ 2,3,5 ]. IPMNs represent a visible dilatation of either the main pancreatic duct or of the side...

...Renata Talar-Wojnarowska; Anita Gasiorowska; Marek Olakowski; Andrzej Lekstan; Paweł Lampe; Ewa Malecka-Panas Background: Neopterin and tissue polypeptide-specific antigen (TPS) have been suggested to be useful in differential diagnosis between pancreatic adenocarcinoma (PA) and chronic...

.... In the following review, we provide a brief introduction to the cell cycle and a discussion of the mechanism underlying the dysregulation of the cell cycle in human cancer. We pay particular attention to pancreatic adenocarcinoma, an aggressive tumor that has a 5-year survival rate of 3–5%, and is the fourth...

...Richard D. Carvajal; Archie Tse; Manish A. Shah; Robert A. Lefkowitz; Mithat Gonen; Lisa Gilman-Rosen; Jeremy Kortmansky; David P. Kelsen; Gary K. Schwartz; Eileen M. O’Reilly Background/Aims: Pancreatic adenocarcinoma (PC) harbors frequent alterations in p16, resulting in cell cycle dysregulation...

...Aude Legoffic; Ezequiel Luis Calvo; Marc Barthet; Jean-Robert Delpero; Jean Charles Dagorn; Juan Lucio Iovanna Background: Genomic alterations present in pancreatic adenocarcinoma have been described only partially. In addition, the relations between these alterations and the aggressiveness...

..., Technische Universität München, Munich, bDepartment of General Surgery, University of Heidelberg, Heidelberg, Germany; cDepartment of General Surgery, Zhong-Da Hospital, Southeast University, Nanjing, China Key Words Pancreatic adenocarcinoma Stellate cells Endocrine gland-derived vascular endothelial...

... synthase kinase-3 Glycogen synthase β-Catenin NFĸB Pancreatic adenocarcinoma Heterochromatin National Institutes of Health (NIH) 10.13039/100000002 Molecular Pathways Pancreatology 2007;7:398 402 DOI: 10.1159/000108955 Published online: October 1, 2007 Primers on Molecular Pathways...

... study evaluated tumor staging and resectionof pancreatic adenocarcinoma (PaC) according to previous Body Mass Index (BMI), BMI on admission and DM duration. Methods: A retrospective analysis of 151 consecutive patients with PaC was performed: 73 were evaluated according to BMI preceding tumor-related...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Cyclooxygenase-2 Pancreatic adenocarcinoma Chronic pancreatitis Pancreatic intraepithelial neoplasia Original Paper Pancreatology 2005;5:361 369 DOI: 10.1159/000086536 Received: July 15, 2004...

... with pancreatic cancer have been observed to have depressed immune responses, suggesting that immunotherapy might have limited utility in this group of patients. We sought to determine whether patients undergoing postresection or primary medical treatment for pancreatic adenocarcinoma were immunocompetent...

... fourth of patients. 1 09 2003 17 02 2004 16 8 2004 Pancreatic adenocarcinoma Laparoscopy Endoscopic ultrasonography Spiral computed tomography Staging Original Paper Pancreatology 2004;4:436 440 DOI: 10.1159/000079617 Received: September 1, 2003 Accepted after revision...

... adenocarcinoma Chemotherapy Original Paper Pancreatology 2003;3:367 374 DOI: 10.1159/000073651 Received: October 11, 2002 Revised and accepted: March 20, 2003 Published online: September 24, 2003 Synergistic Activity of Gamma-Linolenic Acid and Cytotoxic Drugs against Pancreatic Adenocarcinoma Cell Lines P.A...

...-cadherin and catenins and loss of expression, as well as mutations, has been described in a number of epithelial cancers. The aim of this study was to evaluate the expression of E-cadherin and catenins in pancreatic adenocarcinoma tissue, and to examine the relationship between these expression and various...